View ValuationZeotech 향후 성장Future 기준 점검 6/6Zeotech (는) 각각 연간 79.9% 및 52.2% 수익과 수익이 증가할 것으로 예상됩니다.핵심 정보79.9%이익 성장률n/aEPS 성장률Metals and Mining 이익 성장14.5%매출 성장률52.2%향후 자기자본이익률30.60%애널리스트 커버리지Low마지막 업데이트17 Dec 2025최근 향후 성장 업데이트업데이트 없음모든 업데이트 보기Recent updatesReported Earnings • Mar 16First half 2026 earnings released: AU$0.002 loss per share (vs AU$0.001 loss in 1H 2025)First half 2026 results: AU$0.002 loss per share (further deteriorated from AU$0.001 loss in 1H 2025). Net loss: AU$3.24m (loss widened 192% from 1H 2025). Revenue is forecast to grow 52% p.a. on average during the next 3 years, compared to a 7.9% growth forecast for the Metals and Mining industry in Australia. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.New Risk • Mar 04New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: AU$139.9m (US$99.0m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Revenue is less than US$1m (AU$966k revenue, or US$683k). Minor Risk Market cap is less than US$100m (AU$139.9m market cap, or US$99.0m).공시 • Oct 03Zeotech Limited, Annual General Meeting, Nov 28, 2025Zeotech Limited, Annual General Meeting, Nov 28, 2025.Reported Earnings • Oct 01Full year 2025 earnings released: AU$0.002 loss per share (vs AU$0.003 loss in FY 2024)Full year 2025 results: AU$0.002 loss per share (improved from AU$0.003 loss in FY 2024). Net loss: AU$4.41m (loss narrowed 20% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 34% per year, which means it is well ahead of earnings.공시 • Sep 30Zeotech Limited has completed a Follow-on Equity Offering in the amount of AUD 13 million.Zeotech Limited has completed a Follow-on Equity Offering in the amount of AUD 13 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 162,500,000 Price\Range: AUD 0.08 Discount Per Security: AUD 0.0056 Transaction Features: Subsequent Direct ListingNew Risk • Sep 28New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$1.8m free cash flow). Earnings have declined by 13% per year over the past 5 years. Revenue is less than US$1m (AU$977k revenue, or US$640k). Minor Risk Latest financial reports are more than 6 months old (reported December 2024 fiscal period end).분석 기사 • Jul 22Companies Like Zeotech (ASX:ZEO) Are In A Position To Invest In GrowthThere's no doubt that money can be made by owning shares of unprofitable businesses. For example, Zeotech ( ASX:ZEO...공시 • Mar 31Zeotech Limited Appoints Shane Graham as an Executive Director (Technical), Effective April 7, 2025Zeotech Limited announced that the appointment of experienced building materials and construction technology executive Mr. Shane Graham as an Executive Director (Technical), effective April 7. Mr. Graham is a high-performing business leader with over 30 years of extensive experience in the building materials sector. This includes executive management roles with two of Australia's leading building materials companies, including 5 years at Holcim (Australia) Pty Limited ("Holcim") and over 20 years at Boral Limited ("Boral"). At Holcim, he held the positions of Executive General Manager Commercial & Major Projects in this role he was responsible for securing Major Infrastructure project opportunities and Executive General Manager of Humes Australia. Prior to joining Holcim, he held various Executive General Management roles at Boral, including Executive General Manager Queensland with National oversight of Boral Concrete, before progressing to the position of Executive General Manager Major Projects & Project Management Office. In this role, Mr. Graham was responsible for securing major construction projects and maintaining senior relationships with all major national and international contractors. Furthermore, Mr. Graham has experience leading a resources and infrastructure services group that provided civil contracting, mining services, construction materials, transport, and bulk haulage services.Reported Earnings • Mar 15First half 2025 earnings released: AU$0.001 loss per share (vs AU$0.002 loss in 1H 2024)First half 2025 results: AU$0.001 loss per share (improved from AU$0.002 loss in 1H 2024). Net loss: AU$1.11m (loss narrowed 71% from 1H 2024). Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 9% per year.New Risk • Mar 12New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$1.8m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$1.8m free cash flow). Earnings have declined by 13% per year over the past 5 years. Revenue is less than US$1m (AU$977k revenue, or US$615k). Minor Risk Market cap is less than US$100m (AU$76.0m market cap, or US$47.9m).공시 • Oct 04Zeotech Limited, Annual General Meeting, Nov 22, 2024Zeotech Limited, Annual General Meeting, Nov 22, 2024.Reported Earnings • Sep 28Full year 2024 earnings released: AU$0.003 loss per share (vs AU$0.002 loss in FY 2023)Full year 2024 results: AU$0.003 loss per share (further deteriorated from AU$0.002 loss in FY 2023). Net loss: AU$5.53m (loss widened 124% from FY 2023). Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has fallen by 28% per year, which means it is performing significantly worse than earnings.분석 기사 • Aug 29Here's Why We're Not Too Worried About Zeotech's (ASX:ZEO) Cash Burn SituationThere's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...공시 • Aug 21+ 1 more updateZeotech Limited Appoints Scott Burkhart as Chief Operating OfficerZeotech Limited announced that As part of the appointment, the current CEO, Scott Burkhart, will be appointed as Chief Operating Officer ('COO'). Mr. Burkhart will continue to play a significant role as COO, focusing on all operational and financial aspects of the Company. He will contribute to executing Zeotech's strategic direction and maintaining key business relationships with industry stakeholders, which he developed during his tenure as CEO.분석 기사 • May 07Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth PlansJust because a business does not make any money, does not mean that the stock will go down. For example, although...Recent Insider Transactions Derivative • Mar 28MD & Director exercised options and sold AU$232k worth of stockOn the 27th of March, Peter Zardo exercised 20.00m options to receive shares at no cost, then sold 20m of them for an average price of -AU$0.012 per share and kept the remainder. Since June 2023, Peter has owned 57.81m shares directly. Company insiders have collectively bought AU$188k more than they sold, via options and on-market transactions, in the last 12 months.Reported Earnings • Mar 15First half 2024 earnings released: AU$0.002 loss per share (vs AU$0 in 1H 2023)First half 2024 results: AU$0.002 loss per share (further deteriorated from AU$0 in 1H 2023). Net loss: AU$3.84m (loss widened 452% from 1H 2023). Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 28% per year, which means it is significantly lagging earnings.New Risk • Mar 14New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$2.6m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.6m free cash flow). Share price has been highly volatile over the past 3 months (19% average weekly change). Earnings have declined by 25% per year over the past 5 years. Revenue is less than US$1m (AU$755k revenue, or US$500k). Minor Risks Shareholders have been diluted in the past year (5.7% increase in shares outstanding). Market cap is less than US$100m (AU$50.3m market cap, or US$33.3m).New Risk • Feb 20New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Australian stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 23% per year over the past 5 years. Revenue is less than US$1m (AU$1.1m revenue, or US$701k). Minor Risks Shareholders have been diluted in the past year (5.7% increase in shares outstanding). Significant insider selling over the past 3 months (AU$82k sold). Market cap is less than US$100m (AU$43.3m market cap, or US$28.3m).분석 기사 • Jan 20Is Zeotech (ASX:ZEO) In A Good Position To Deliver On Growth Plans?There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...Recent Insider Transactions • Nov 24Insider recently sold AU$82k worth of stockOn the 21st of November, John Goody sold around 2m shares on-market at roughly AU$0.041 per share. This transaction amounted to 2.1% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of AU$218k more than they bought in the last 12 months.New Risk • Nov 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 12% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 23% per year over the past 5 years. Revenue is less than US$1m (AU$1.1m revenue, or US$684k). Minor Risks Share price has been volatile over the past 3 months (12% average weekly change). Shareholders have been diluted in the past year (7.1% increase in shares outstanding). Market cap is less than US$100m (AU$89.9m market cap, or US$57.3m).공시 • Oct 10+ 1 more updateZeotech Limited Announces CEO Changes, Anticipates to Occur from 1 November 2023Zeotech Limited provided the following update on changes to its executive management, which will further strengthen the Company's capabilities and highlight Zeotech's ongoing focus on commercial development. The company announced that current CEO, Mr. Alister Morrison, will transition to the role of Chief Development Officer (CDO), and Zeotech's COO, Mr. Scott Burkhart, will undertake the role of CEO . The changes are anticipated to occur from 1 November 2023. Mr. Burkhart joined Zeotech in October 2021 as COO, and during this time has played an integral role in establishing the Company's operational platform and execution of its strategy. Scott has worked closely on the Company's projects at Griffith University and has a deep understanding of its technology and investment proposition. He holds a Bachelor of Business (B.Bus) in Management and Economics from Auckland University of Technology, New Zealand. Mr. Morrison will continue to play a significant executive role as CDO, with a focus on accelerating commercialisation through oversight and implementation of the ongoing demonstration plant planning, new business development and market analysis, and managing key regional stakeholder relationships and research programs at The University of Queensland (UQ). The Company is confident that these changes considerably strengthen its management capability, by enabling a dedicated focus on commercial development, whilst supporting a hands-on approach to management delivery of Zeotech's business strategy over the medium to long term.공시 • Oct 05Zeotech Limited, Annual General Meeting, Nov 23, 2023Zeotech Limited, Annual General Meeting, Nov 23, 2023.Reported Earnings • Sep 21Full year 2023 earnings released: AU$0.002 loss per share (vs AU$0.003 loss in FY 2022)Full year 2023 results: AU$0.002 loss per share (improved from AU$0.003 loss in FY 2022). Net loss: AU$2.47m (loss narrowed 42% from FY 2022). Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 58% per year, which means it is tracking significantly ahead of earnings growth.New Risk • Sep 10New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$4.3m free cash flow). Earnings have declined by 28% per year over the past 5 years. Revenue is less than US$1m (AU$1.1m revenue, or US$670k). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Shareholders have been diluted in the past year (9.2% increase in shares outstanding). Market cap is less than US$100m (AU$80.2m market cap, or US$51.1m).Recent Insider Transactions • Mar 17MD, COO & Director recently sold AU$135k worth of stockOn the 15th of March, Peter Zardo sold around 2m shares on-market at roughly AU$0.057 per share. This transaction amounted to 3.9% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Peter's only on-market trade for the last 12 months.Reported Earnings • Mar 11First half 2023 earnings released: EPS: AU$0 (vs AU$0.001 loss in 1H 2022)First half 2023 results: EPS: AU$0 (improved from AU$0.001 loss in 1H 2022). Net loss: AU$694.5k (loss narrowed 69% from 1H 2022). Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 128% per year, which means it is tracking significantly ahead of earnings growth.공시 • Dec 14Zeotech Limited Appoints Alister Morrison as Chief Executive Officer, Effective 13 March 2023Zeotech Limited announced that Mr. Alister Morrison (MSc, GAICD, ACEcD) has been appointed as Chief Executive Officer (CEO), effective 13 March 2023. Morrison is an accomplished senior executive with 25-years of strategic international experience, mainly across the energy, natural resources and early-stage technology commercialisation sectors. He has worked for a range of organizations including US and UK listed companies and has a track record in raising capital, mergers and acquisitions (M&A), building and managing high performance teams, developing technical assets and driving corporate growth. Prior to joining Zeotech, Mr. Morrison will have spent approximately five years at UniQuest, the University of Queensland's ("UQ") main commercialisation company, as Senior Director & Head of Physical Sciences, based in Brisbane, Australia. During his time at UniQuest, he led the initial commercialisation of the Company's proprietary mineral processing innovation and maintained contractual management oversight of the main research programs undertaken at UQ, and in doing so acquired an intimate understanding of Zeotech's core intellectual property (IP), technology development roadmap, and ongoing commercialisation pathway.Recent Insider Transactions Derivative • Dec 02MD, COO & Director exercised options to buy AU$490k worth of stock.On the 28th of November, Peter Zardo exercised options to buy 10m shares at a strike price of around AU$0.036, costing a total of AU$360k. This transaction amounted to 23% of their direct individual holding at the time of the trade. Since December 2021, Peter has owned 43.38m shares directly. Company insiders have collectively bought AU$89k more than they sold, via options and on-market transactions, in the last 12 months.공시 • Nov 28Zeotech Limited Announces Successful Completion of Pilot Program Accelerates Technology DevelopmentZeotech Limited advised it has successfully concluded the pilot plant ("Pilot") research program for its novel and proprietary mineral processing technology with The University of Queensland ("UQ") School of Chemical Engineering and UniQuest, UQ's commercialisation company. The Pilot has been in operation at UQ since February 2021 and has achieved its principal objectives by demonstrating a continuous closed-loop circuit from lithium process by- product (leached spodumene) and kaolin feedstock options, providing important process validation of the patent-pending technology. HIGHLIGHTS: Pilot research program successfully completed for novel and proprietary mineral processing technology with UQ and UniQuest The Pilot has provided important validation for the Company's mineral processing innovation by demonstrating multiple continuous closed-loop circuits from dual feedstock options Recent performance runs and process optimisation has generated over 20kg of manufactured zeolite product Development will now be accelerated under two parallel work streams: Technology associated with lithium process by-product to be advanced by the Resources Technology and Critical Minerals Processing Trailblazer Program ("Trailblazer"). Development of the technology from kaolin feedstock will be undertaken at the Company's recently established lab facility at Brisbane Technology Park, following commissioning of a scaled-up in-house Pilot. Preparation of product specification and safety data sheets for Zeotech's manufactured zeolite products are well advanced, and will support marketing activity when providing manufactured zeolite product samples to potential offtake or joint venture partners.분석 기사 • Nov 21Increases to CEO Compensation Might Be Put On Hold For Now at Zeotech Limited (ASX:ZEO)CEO Peter Zardo has done a decent job of delivering relatively good performance at Zeotech Limited ( ASX:ZEO...Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Non-Executive Chairman Sylvia Tulloch was the last director to join the board, commencing their role in 2020. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Oct 04Zeotech Limited, Annual General Meeting, Nov 28, 2022Zeotech Limited, Annual General Meeting, Nov 28, 2022.Reported Earnings • Sep 21Full year 2022 earnings released: AU$0.003 loss per share (vs AU$0.002 loss in FY 2021)Full year 2022 results: AU$0.003 loss per share (further deteriorated from AU$0.002 loss in FY 2021). Net loss: AU$4.23m (loss widened 45% from FY 2021). Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has increased by 55% per year, which means it is well ahead of earnings.공시 • Jul 28Zeotech Limited, Annual General Meeting, Aug 31, 2022Zeotech Limited, Annual General Meeting, Aug 31, 2022, at 14:00 E. Australia Standard Time. Location: Hyatt Hotel Canberra, 120 Commonwealth Ave, Yarralumla, ACT 2600 Yarrabah Australia Agenda: General Meeting of Shareholders.공시 • May 31Zeotech Limited Achieves Successful Continuous Closed- Loop Circuit, Utilising Lithium Process By-Product Feedstock (Leached Spodumene) to Produce Pure Linde Type A Manufactured ZeoliteZeotech Limited advised that it has achieved a successful continuous closed- loop circuit, utilising lithium process by-product feedstock (leached spodumene) to produce pure Linde Type A manufactured zeolite. This demonstration of the Company's dual-feed pilot is a significant milestone in the program with both leached spodumene and kaolin feedstock options being processed through the circuit. The achievement of multiple closed-looped circuit runs utilising lithium process by-product provides important validation of the Company's proprietary flowsheet and will allow personnel from The University of Queensland ("UQ") and the Company to commence project planning for The Trailblazer University Program ("Trailblazer"), which includes industry partner, Covalent Lithium Pty Limited. Since receiving (new) leached spodumene samples in December 2021, UQ researchers have completed over 80 optimisation batch tests and 25 continuous tests completed on individual process steps, involving leaching, filtration/decanting, and precipitation. The pilot has produced over 3 kgs of pure Linde Type A manufactured zeolite product utilising lithium process by-product as feedstock. The pilot program's focus on lithium process by-product delivered an excellent outcome, highlighted by the Company being named as an industry partner in the successful Resources Technology and Critical Minerals Processing Trailblazer Program, led by Curtin University 2 in April 2022. The Trailblazer project will accelerate the commercialisation of Zeotech's proprietary cleantech innovation for lithium process by-product in collaboration with project partners, UQ and Covalent. The Trailblazer grant program provides Federal Government funding to select universities to boost prioritised research and development and drive commercialisation outcomes with industry partners. Next Steps: The completion of a successful continuous closed-loop circuit under the conditions of Zeotech's proprietary flowsheet represents a major step in accelerating Trailblazer planning, with the project's objective of constructing and commissioning a large-scale demonstration plant. Focus on the Company's dual-feed pilot program will remain on lithium process by-product until end of June 2022, in conjunction with commencement of Trailblazer project planning. Attention will then return to kaolin feedstock in early July 2022, following a successful continuous closed-loop circuit utilising Toondoon kaolin feedstock in November 2021.Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Non-Executive Chairman Sylvia Tulloch was the last director to join the board, commencing their role in 2020. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.분석 기사 • Mar 22Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth PlansJust because a business does not make any money, does not mean that the stock will go down. For example, although...Reported Earnings • Mar 08First half 2022 earnings: Revenues and EPS in line with analyst expectationsFirst half 2022 results: AU$0.001 loss per share (vs AU$0.001 loss in 1H 2021). Net loss: AU$2.22m (loss widened 32% from 1H 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has increased by 114% per year, which means it is well ahead of earnings.공시 • Feb 24Zeotech Limited to Be Deleted from Other OTCZeotech Limited's ordinary shares (Australia) will be deleted from Other OTC effective February 23, 2022. The deletion is due to Inactive Security.공시 • Nov 30Zeotech Limited Announces Pilot Program UpdateZeotech Limited announced that it has successfully completed its first continuous closed-loop circuit, utilising kaolin feedstock to produce pure Linde Type A synthetic zeolite product. This marks a significant step in progressing the Company's dual-feed pilot program. Successful bench-scale continuous closed-loop circuit achieved utilising kaolin feedstock to produce pure Linde Type A synthetic zeolite product. Over 110 optimisation batch tests undertaken using Toondoon kaolin and Li process by-product samples, undertaken since May 2021. Over 30 continuous tests completed on individual process steps, involving leaching, filtration/decanting, and precipitation. Plant and equipment procurement underway, with construction and commissioning of pilot plant on track to commence early First Quarter 2022. During the H2 2021, the team at UQ completed in excess of 155 batch and continuous test runs. This work, together with the earlier start date on kaolin test-work, has led to successful development of the first continuous closed-loop circuit utilising Toondoon kaolin as feedstock to produce pure Linde Type A synthetic zeolite product. Since June 2021, UQ researchers have completed over 70 optimisation batch tests across a range leaching and precipitation configurations from two separate samples of Li process by- product. Continuous tank reactor precipitation work has been successfully completed and the team is currently undertaking continuous leaching runs. The inclusion of two separate Li process by-product samples to the pilot program, has increased the variables in validating ZEO's proprietary flowsheet process steps. Despite this, Zeotech and UQ expect to achieve a continuous closed-loop circuit in the near term. The completion of a successful continuous closed-loop circuit under the conditions of Zeotech's proprietary flowsheet, represents a major step in developing the configuration and design data required for scale-up to pilot line construction and commissioning, which is scheduled to commence First Quarter 2022. The focus for the remainder of 2021 is aimed at further optimisation of process steps targeted at achieving a continuous closed-loop circuit utilising Li process by-product. In addition, procurement of plant and equipment for the pilot line set-up has accelerated with key items scheduled for delivery early 2022.분석 기사 • Oct 27Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth PlansEven when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...Reported Earnings • Sep 28Full year 2021 earnings released: AU$0.002 loss per share (vs AU$0.003 loss in FY 2020)Full year 2021 results: Net loss: AU$2.92m (loss widened 5.9% from FY 2020). Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has increased by 103% per year, which means it is tracking significantly ahead of earnings growth.공시 • May 24Zeotech Limited announced that it expects to receive AUD 3.7005 million in fundingZeotech Limited (ASX:ZEO) announced private placement of 52,864,286 shares at a price of AUD 0.07 per share for gross proceeds of AUD 3,700,500 on May 24, 2021. The transaction will include participation from sophisticated investors. The transaction has been approved by the board of directors of the company. The shares are expected to be issued on May 28, 2021.분석 기사 • Apr 19We Think Zeotech (ASX:ZEO) Can Afford To Drive Business GrowthThere's no doubt that money can be made by owning shares of unprofitable businesses. Indeed, Zeotech ( ASX:ZEO ) stock...Reported Earnings • Mar 18First half 2021 earnings released: AU$0.001 loss per share (vs AU$0.001 loss in 1H 2020)First half 2021 results: Net loss: AU$1.68m (loss widened 150% from 1H 2020). Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has increased by 87% per year, which means it is tracking significantly ahead of earnings growth.분석 기사 • Feb 18Trade Alert: Anthony Sheridan At Zeotech Limited (ASX:ZEO), Has Just Spent AU$780k Buying 8.8% More SharesZeotech Limited ( ASX:ZEO ) shareholders (or potential shareholders) will be happy to see that insider Anthony Sheridan...공시 • Feb 16Zeotech Limited Pilot Plant Program CommencesZeotech Limited announce that it has committed to the development and construction of a pilot plant and is undertaking an extensive test-work- program to further optimise the flowsheet of the Company's low-cost synthetic zeolite manufacturing technology to de-risk future commercial investment. Following the positive outcomes of extensive lab-scale work undertaken by researchers from UQ, since lodging a core provisional patent application in June 2019, for the manufacture (synthesis) of synthetic zeolites from kaolin or clay-based materials i.e., mine tailings or process residues, Zeotech has committed to undertake a comprehensive pilot plant program. The program will incorporate an artificial intelligence (machine learning) component to enhance understanding and application of piloting results, by building a comprehensive dataset and predictive capabilities. The pilot plant will provide Zeotech with increased confidence and certainty on the engineered flowsheet design and operational performance of the process circuit before committing to commercial zeolite production facilities. Zeotech's decision to proceed with the pilot plant is supported by continued positive lab-scale results delivered by research funded at UQ and based on the understanding that a well designed and constructed pilot plant is an integral component in the decision-making process required to determine critical economics and underpin future commercial plant strategy and financing. The pilot plant should also demonstrate the efficiency of Zeotech's novel and proprietary mineral processing technology and proficiency of the process design by producing very high-grade material on a continuous, customer sample scale, basis. The program's aim is to commission pilot plant in the December Quarter 2021. The University of Queensland's Associate Professor James Vaughan and Dr. Hong (Marco) Peng from the School of Chemical Engineering will provide technical support for the pilot plant program's studies. Pilot Plant Funding: As announced on 5 January 2021, the Company raised $1.7 million to support funding of the pilot plant program. It is important to note that as the pilot plant research program revolves around validating Zeotech's patent-pending technology, it is classified as Research and Development and accordingly it will be eligible for the Australian Government's R&D tax incentive scheme. Zeotech targeting Type A zeolites: The Company's novel and proprietary mineral processing technology provides potential access to the AUD 2.6 billion global Type A zeolite market, with a focus on high value molecular sieve zeolites, which achieve prices in excess of AUD 2,850 per tonne.공시 • Feb 08Zeotech Limited Executes Research Agreement with UQ to Evaluate Carbon Capture Using Synthetic ZeolitesZeotech Limited announced it has executed a dedicated research agreement with The University of Queensland ("UQ") to evaluate the performance of synthetic zeolites in the field of carbon capture, a market that is projected to reach USD 6.15 billion by 2027. Zeotech is assessing how to leverage its novel and proprietary mineral processing technology for the low-cost synthesis of synthetic zeolites to deliver economically feasible environmental management solutions for carbon capture. The carbon capture research program will commence 1 March 2021 and will be carried out over a nine-month period. The program will consist of the following stages: Characterisation of synthetic zeolites and commercial adsorbents - this will involve building a database of different types of the synthetic zeolites and commercial adsorbents, following their characterisation, and comparing properties; Carbon dioxide adsorption capacity and selectivity measurement - this will involve measuring and comparing the carbon dioxide (CO2) adsorption capacity of the synthetic zeolites and commercial adsorbents. The synthetic zeolites selectivity of CO2 over other gases such as N2 will also be investigated; and Granulation study of synthetic zeolite products - this will involve an agglomeration study of synthetic zeolites will be carried out in this stage. The preparation process of the synthetic zeolite agglomerate will be explored, and the carbon capture performance of these bulk adsorbents will be evaluated. Zeotech's carbon capture research program will also incorporate detailed economic analysis of: The use of different synthetic zeolites produced by Zeotech and the commercial adsorbents for carbon capture and selectivity; and Granulation of synthetic zeolite products and the commercial adsorbents for carbon capture and selectivity. Growing environmental concerns regarding global warming and climate change have motivated researchers to develop more efficient and improved processes for CO2 capture from large point sources of CO2. Adsorption processes using solid sorbents capable of capturing CO2 from flue gas streams have shown many potential advantages, compared to other conventional CO2 capture processes using aqueous amine solvents. Microporous crystalline framework materials such as synthetic zeolites are widely used in the field of gas separation and purification, commercially. Synthetic zeolites have shown promising results for separation of CO2 from gas streams and there is much published literature concerning CO2 adsorption over different types of zeolites. Zeotech's aim is to leverage the economic benefits of its synthetic zeolite mineral processing technology. For example, UQ's Chemical Engineering team has demonstrated up to 70% reduction in energy consumption in the thermal activation stage and up to 80% reduction in production time in the subsequent zeolite precipitation steps, in the synthesis of synthetic zeolites, coupled with the excellent structural properties of the synthetic zeolite to produce low-cost solid adsorbent for commercial CO2 capture to reduce greenhouse gases. Zeotech is also pleased to advise it continues to grow its in-house technical team, with the employment of Mr. John Vogrin on a full-time basis. Mr. Vogrin is a PhD candidate (awaiting examination) and Alumina Quality Workshop scholar in the School of Chemical Engineering at The University of Queensland. He has recently submitted his thesis on the hydrothermal synthesis of zeolites in industrial processes such as the Bayer process and anion incorporation into their structure. John's expertise includes XRD (quantitative/qualitative), ICP, XRF, FE-SEM, TGA, PSD and UV-Raman spectroscopy for materials characterisation. His latest publication is 'Influence of Chloride on Sodium Aluminosilicate Solubility in Bayer Liquor'. He holds a Bachelor of Engineering (B.E.) in Chemical and Metallurgical Engineering (Honours).분석 기사 • Jan 25Here's What Zeotech Limited's (ASX:ZEO) Shareholder Ownership Structure Looks LikeIf you want to know who really controls Zeotech Limited ( ASX:ZEO ), then you'll have to look at the makeup of its...공시 • Jan 12Zeotech Limited Announces resignation of John Goody as Non-Executive DirectorZeotech Limited announced that Mr. John Goody has resigned as a non-executive director of the Company.공시 • Oct 05Metalsearch Limited Announces Participating in Agronomic Trials to Evaluate the Performance of Synthetic Zeolites Across A Range of Agricultural ApplicationsMetalsearch Limited announced it is participating in agronomic trials to evaluate the performance of synthetic zeolites across a range of agricultural applications. The trials will be undertaken in collaboration with Griffith University and the University of Queensland. MSE is exploring the application of synthetic zeolites in the agricultural industry after being introduced to Griffith University by the University of Queensland, in order to link into an agronomic zeolite trial program to be conducted over the next 6-9 months. The program will consist of: Zeolite sorption and desorption experimentation; Agronomic performance testing via glasshouse pot trials, benchmarking against conventional soil amendment; Assessing plant growth performance under optimal water-availability and drought conditions; and Pesticide-destruction experiments - testing the photocatalytic oxidation potential of zeolites amended with commonly-encountered pesticides in Australian agriculture. MSE considers one of the inhibitors to the wider commercial adoption of synthetic zeolites in the agricultural sector has been the cost of production. The ability to produce low-cost synthetic zeolites from kaolin or suitable zero-cost mine waste streams using the University of Queensland's developed mineral processing technology enables MSE to tangibly investigate end-product strategies to exploit its patent-pending zeolite mineral processing technologies. Zeolites have a range of agricultural applications, such as; soil amendment i.e. improve water-holding capacity and aid fertilizer uptake; fertilizer additives i.e. aid slow-release; animal feed additives i.e. dietary supplement and mycotoxin adsorption; animal waste treatment i.e. increasing nitrogen retentivity and controlling moisture; and aquaculture i.e. remove ammonium, oxygen generation and as a feed supplement. Griffith University's agronomic zeolite trials will incorporate detailed economic analysis, which may potentially translate into a more intensive collaboration between Griffith University, the University of Queensland and MSE - the objective being to set the foundation for specialised synthetic zeolite Agri-product development studies.공시 • Jul 31Metalsearch Limited announced that it has received AUD 1.6575 million in fundingLaconia Resources Limited (ASX:LCR) a private placement of 127,500,000 common shares for AUD 0.013 per share for gross proceeds of AUD 1,657,500 on July 28, 2020. The transaction included participation from sophisticated investors.이익 및 매출 성장 예측ASX:ZEO - 애널리스트 향후 추정치 및 과거 재무 데이터 (AUD Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수6/30/20286723252516/30/20273811121216/30/2026331144112/31/20251-7-4-4N/A9/30/20251-5-4-4N/A6/30/20251-4-4-3N/A3/31/20251-4-3-3N/A12/31/20241-3-2-2N/A9/30/20241-4-2-2N/A6/30/20241-6-3-3N/A3/31/20241-6-3-2N/A12/31/20231-6-3-2N/A9/30/20231-4-3-2N/A6/30/20231-2-4-2N/A3/31/20231-3-4-2N/A12/31/20221-3-4-2N/A9/30/20221-3-4-2N/A6/30/20221-4-3-2N/A3/31/20221-4-3-3N/A12/31/20211-3-3-3N/A9/30/20210-3-3-2N/A6/30/20210-3-3-2N/A3/31/20210-3-2-2N/A12/31/20200-4-2-2N/A9/30/20200-3-2-2N/A6/30/20200-3-2-2N/A3/31/20200-2-2-1N/A12/31/20190-1-1-1N/A9/30/20190-1N/A-1N/A6/30/20190-1N/A-1N/A3/31/20190-1N/A-1N/A12/31/20180-1N/A-1N/A9/30/20180-1N/A-1N/A6/30/20180-2N/A-2N/A3/31/20180-1N/A-1N/A12/31/20170-1N/A-1N/A9/30/20170-1N/A-1N/A6/30/201700N/A0N/A3/31/20170-1N/A0N/A12/31/20160-1N/A0N/A9/30/20160-1N/A0N/A6/30/20160-1N/A0N/A3/31/20160-3N/A0N/A12/31/20150-5N/A-1N/A9/30/20150-6N/A-1N/A6/30/20150-6N/A-1N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: ZEO 은 향후 3년 동안 수익을 낼 것으로 예상되며, 이는 절약률(3.6%)보다 빠른 성장으로 간주됩니다.수익 vs 시장: ZEO (는) 향후 3년 동안 평균 시장 성장보다 높은 수익을 올릴 것으로 예상됩니다.고성장 수익: ZEO 향후 3년 내에 수익을 낼 것으로 예상됩니다.수익 대 시장: ZEO 의 수익(연간 52.2%)이 Australian 시장(연간 6.1%)보다 빠르게 성장할 것으로 예상됩니다.고성장 매출: ZEO 의 수익(연간 52.2%)은 연간 20%보다 빠르게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: ZEO의 자본 수익률은 3년 후 30.6%로 높을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/21 00:43종가2026/05/21 00:00수익2025/12/31연간 수익2025/06/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Zeotech Limited는 1명의 분석가가 다루고 있습니다. 이 중 1명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Liam SchofieldMorgans Financial Limited
Reported Earnings • Mar 16First half 2026 earnings released: AU$0.002 loss per share (vs AU$0.001 loss in 1H 2025)First half 2026 results: AU$0.002 loss per share (further deteriorated from AU$0.001 loss in 1H 2025). Net loss: AU$3.24m (loss widened 192% from 1H 2025). Revenue is forecast to grow 52% p.a. on average during the next 3 years, compared to a 7.9% growth forecast for the Metals and Mining industry in Australia. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.
New Risk • Mar 04New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: AU$139.9m (US$99.0m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Revenue is less than US$1m (AU$966k revenue, or US$683k). Minor Risk Market cap is less than US$100m (AU$139.9m market cap, or US$99.0m).
공시 • Oct 03Zeotech Limited, Annual General Meeting, Nov 28, 2025Zeotech Limited, Annual General Meeting, Nov 28, 2025.
Reported Earnings • Oct 01Full year 2025 earnings released: AU$0.002 loss per share (vs AU$0.003 loss in FY 2024)Full year 2025 results: AU$0.002 loss per share (improved from AU$0.003 loss in FY 2024). Net loss: AU$4.41m (loss narrowed 20% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 34% per year, which means it is well ahead of earnings.
공시 • Sep 30Zeotech Limited has completed a Follow-on Equity Offering in the amount of AUD 13 million.Zeotech Limited has completed a Follow-on Equity Offering in the amount of AUD 13 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 162,500,000 Price\Range: AUD 0.08 Discount Per Security: AUD 0.0056 Transaction Features: Subsequent Direct Listing
New Risk • Sep 28New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$1.8m free cash flow). Earnings have declined by 13% per year over the past 5 years. Revenue is less than US$1m (AU$977k revenue, or US$640k). Minor Risk Latest financial reports are more than 6 months old (reported December 2024 fiscal period end).
분석 기사 • Jul 22Companies Like Zeotech (ASX:ZEO) Are In A Position To Invest In GrowthThere's no doubt that money can be made by owning shares of unprofitable businesses. For example, Zeotech ( ASX:ZEO...
공시 • Mar 31Zeotech Limited Appoints Shane Graham as an Executive Director (Technical), Effective April 7, 2025Zeotech Limited announced that the appointment of experienced building materials and construction technology executive Mr. Shane Graham as an Executive Director (Technical), effective April 7. Mr. Graham is a high-performing business leader with over 30 years of extensive experience in the building materials sector. This includes executive management roles with two of Australia's leading building materials companies, including 5 years at Holcim (Australia) Pty Limited ("Holcim") and over 20 years at Boral Limited ("Boral"). At Holcim, he held the positions of Executive General Manager Commercial & Major Projects in this role he was responsible for securing Major Infrastructure project opportunities and Executive General Manager of Humes Australia. Prior to joining Holcim, he held various Executive General Management roles at Boral, including Executive General Manager Queensland with National oversight of Boral Concrete, before progressing to the position of Executive General Manager Major Projects & Project Management Office. In this role, Mr. Graham was responsible for securing major construction projects and maintaining senior relationships with all major national and international contractors. Furthermore, Mr. Graham has experience leading a resources and infrastructure services group that provided civil contracting, mining services, construction materials, transport, and bulk haulage services.
Reported Earnings • Mar 15First half 2025 earnings released: AU$0.001 loss per share (vs AU$0.002 loss in 1H 2024)First half 2025 results: AU$0.001 loss per share (improved from AU$0.002 loss in 1H 2024). Net loss: AU$1.11m (loss narrowed 71% from 1H 2024). Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 9% per year.
New Risk • Mar 12New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$1.8m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$1.8m free cash flow). Earnings have declined by 13% per year over the past 5 years. Revenue is less than US$1m (AU$977k revenue, or US$615k). Minor Risk Market cap is less than US$100m (AU$76.0m market cap, or US$47.9m).
공시 • Oct 04Zeotech Limited, Annual General Meeting, Nov 22, 2024Zeotech Limited, Annual General Meeting, Nov 22, 2024.
Reported Earnings • Sep 28Full year 2024 earnings released: AU$0.003 loss per share (vs AU$0.002 loss in FY 2023)Full year 2024 results: AU$0.003 loss per share (further deteriorated from AU$0.002 loss in FY 2023). Net loss: AU$5.53m (loss widened 124% from FY 2023). Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has fallen by 28% per year, which means it is performing significantly worse than earnings.
분석 기사 • Aug 29Here's Why We're Not Too Worried About Zeotech's (ASX:ZEO) Cash Burn SituationThere's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
공시 • Aug 21+ 1 more updateZeotech Limited Appoints Scott Burkhart as Chief Operating OfficerZeotech Limited announced that As part of the appointment, the current CEO, Scott Burkhart, will be appointed as Chief Operating Officer ('COO'). Mr. Burkhart will continue to play a significant role as COO, focusing on all operational and financial aspects of the Company. He will contribute to executing Zeotech's strategic direction and maintaining key business relationships with industry stakeholders, which he developed during his tenure as CEO.
분석 기사 • May 07Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth PlansJust because a business does not make any money, does not mean that the stock will go down. For example, although...
Recent Insider Transactions Derivative • Mar 28MD & Director exercised options and sold AU$232k worth of stockOn the 27th of March, Peter Zardo exercised 20.00m options to receive shares at no cost, then sold 20m of them for an average price of -AU$0.012 per share and kept the remainder. Since June 2023, Peter has owned 57.81m shares directly. Company insiders have collectively bought AU$188k more than they sold, via options and on-market transactions, in the last 12 months.
Reported Earnings • Mar 15First half 2024 earnings released: AU$0.002 loss per share (vs AU$0 in 1H 2023)First half 2024 results: AU$0.002 loss per share (further deteriorated from AU$0 in 1H 2023). Net loss: AU$3.84m (loss widened 452% from 1H 2023). Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 28% per year, which means it is significantly lagging earnings.
New Risk • Mar 14New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$2.6m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.6m free cash flow). Share price has been highly volatile over the past 3 months (19% average weekly change). Earnings have declined by 25% per year over the past 5 years. Revenue is less than US$1m (AU$755k revenue, or US$500k). Minor Risks Shareholders have been diluted in the past year (5.7% increase in shares outstanding). Market cap is less than US$100m (AU$50.3m market cap, or US$33.3m).
New Risk • Feb 20New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Australian stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 23% per year over the past 5 years. Revenue is less than US$1m (AU$1.1m revenue, or US$701k). Minor Risks Shareholders have been diluted in the past year (5.7% increase in shares outstanding). Significant insider selling over the past 3 months (AU$82k sold). Market cap is less than US$100m (AU$43.3m market cap, or US$28.3m).
분석 기사 • Jan 20Is Zeotech (ASX:ZEO) In A Good Position To Deliver On Growth Plans?There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
Recent Insider Transactions • Nov 24Insider recently sold AU$82k worth of stockOn the 21st of November, John Goody sold around 2m shares on-market at roughly AU$0.041 per share. This transaction amounted to 2.1% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of AU$218k more than they bought in the last 12 months.
New Risk • Nov 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 12% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 23% per year over the past 5 years. Revenue is less than US$1m (AU$1.1m revenue, or US$684k). Minor Risks Share price has been volatile over the past 3 months (12% average weekly change). Shareholders have been diluted in the past year (7.1% increase in shares outstanding). Market cap is less than US$100m (AU$89.9m market cap, or US$57.3m).
공시 • Oct 10+ 1 more updateZeotech Limited Announces CEO Changes, Anticipates to Occur from 1 November 2023Zeotech Limited provided the following update on changes to its executive management, which will further strengthen the Company's capabilities and highlight Zeotech's ongoing focus on commercial development. The company announced that current CEO, Mr. Alister Morrison, will transition to the role of Chief Development Officer (CDO), and Zeotech's COO, Mr. Scott Burkhart, will undertake the role of CEO . The changes are anticipated to occur from 1 November 2023. Mr. Burkhart joined Zeotech in October 2021 as COO, and during this time has played an integral role in establishing the Company's operational platform and execution of its strategy. Scott has worked closely on the Company's projects at Griffith University and has a deep understanding of its technology and investment proposition. He holds a Bachelor of Business (B.Bus) in Management and Economics from Auckland University of Technology, New Zealand. Mr. Morrison will continue to play a significant executive role as CDO, with a focus on accelerating commercialisation through oversight and implementation of the ongoing demonstration plant planning, new business development and market analysis, and managing key regional stakeholder relationships and research programs at The University of Queensland (UQ). The Company is confident that these changes considerably strengthen its management capability, by enabling a dedicated focus on commercial development, whilst supporting a hands-on approach to management delivery of Zeotech's business strategy over the medium to long term.
공시 • Oct 05Zeotech Limited, Annual General Meeting, Nov 23, 2023Zeotech Limited, Annual General Meeting, Nov 23, 2023.
Reported Earnings • Sep 21Full year 2023 earnings released: AU$0.002 loss per share (vs AU$0.003 loss in FY 2022)Full year 2023 results: AU$0.002 loss per share (improved from AU$0.003 loss in FY 2022). Net loss: AU$2.47m (loss narrowed 42% from FY 2022). Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 58% per year, which means it is tracking significantly ahead of earnings growth.
New Risk • Sep 10New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$4.3m free cash flow). Earnings have declined by 28% per year over the past 5 years. Revenue is less than US$1m (AU$1.1m revenue, or US$670k). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Shareholders have been diluted in the past year (9.2% increase in shares outstanding). Market cap is less than US$100m (AU$80.2m market cap, or US$51.1m).
Recent Insider Transactions • Mar 17MD, COO & Director recently sold AU$135k worth of stockOn the 15th of March, Peter Zardo sold around 2m shares on-market at roughly AU$0.057 per share. This transaction amounted to 3.9% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Peter's only on-market trade for the last 12 months.
Reported Earnings • Mar 11First half 2023 earnings released: EPS: AU$0 (vs AU$0.001 loss in 1H 2022)First half 2023 results: EPS: AU$0 (improved from AU$0.001 loss in 1H 2022). Net loss: AU$694.5k (loss narrowed 69% from 1H 2022). Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 128% per year, which means it is tracking significantly ahead of earnings growth.
공시 • Dec 14Zeotech Limited Appoints Alister Morrison as Chief Executive Officer, Effective 13 March 2023Zeotech Limited announced that Mr. Alister Morrison (MSc, GAICD, ACEcD) has been appointed as Chief Executive Officer (CEO), effective 13 March 2023. Morrison is an accomplished senior executive with 25-years of strategic international experience, mainly across the energy, natural resources and early-stage technology commercialisation sectors. He has worked for a range of organizations including US and UK listed companies and has a track record in raising capital, mergers and acquisitions (M&A), building and managing high performance teams, developing technical assets and driving corporate growth. Prior to joining Zeotech, Mr. Morrison will have spent approximately five years at UniQuest, the University of Queensland's ("UQ") main commercialisation company, as Senior Director & Head of Physical Sciences, based in Brisbane, Australia. During his time at UniQuest, he led the initial commercialisation of the Company's proprietary mineral processing innovation and maintained contractual management oversight of the main research programs undertaken at UQ, and in doing so acquired an intimate understanding of Zeotech's core intellectual property (IP), technology development roadmap, and ongoing commercialisation pathway.
Recent Insider Transactions Derivative • Dec 02MD, COO & Director exercised options to buy AU$490k worth of stock.On the 28th of November, Peter Zardo exercised options to buy 10m shares at a strike price of around AU$0.036, costing a total of AU$360k. This transaction amounted to 23% of their direct individual holding at the time of the trade. Since December 2021, Peter has owned 43.38m shares directly. Company insiders have collectively bought AU$89k more than they sold, via options and on-market transactions, in the last 12 months.
공시 • Nov 28Zeotech Limited Announces Successful Completion of Pilot Program Accelerates Technology DevelopmentZeotech Limited advised it has successfully concluded the pilot plant ("Pilot") research program for its novel and proprietary mineral processing technology with The University of Queensland ("UQ") School of Chemical Engineering and UniQuest, UQ's commercialisation company. The Pilot has been in operation at UQ since February 2021 and has achieved its principal objectives by demonstrating a continuous closed-loop circuit from lithium process by- product (leached spodumene) and kaolin feedstock options, providing important process validation of the patent-pending technology. HIGHLIGHTS: Pilot research program successfully completed for novel and proprietary mineral processing technology with UQ and UniQuest The Pilot has provided important validation for the Company's mineral processing innovation by demonstrating multiple continuous closed-loop circuits from dual feedstock options Recent performance runs and process optimisation has generated over 20kg of manufactured zeolite product Development will now be accelerated under two parallel work streams: Technology associated with lithium process by-product to be advanced by the Resources Technology and Critical Minerals Processing Trailblazer Program ("Trailblazer"). Development of the technology from kaolin feedstock will be undertaken at the Company's recently established lab facility at Brisbane Technology Park, following commissioning of a scaled-up in-house Pilot. Preparation of product specification and safety data sheets for Zeotech's manufactured zeolite products are well advanced, and will support marketing activity when providing manufactured zeolite product samples to potential offtake or joint venture partners.
분석 기사 • Nov 21Increases to CEO Compensation Might Be Put On Hold For Now at Zeotech Limited (ASX:ZEO)CEO Peter Zardo has done a decent job of delivering relatively good performance at Zeotech Limited ( ASX:ZEO...
Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Non-Executive Chairman Sylvia Tulloch was the last director to join the board, commencing their role in 2020. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Oct 04Zeotech Limited, Annual General Meeting, Nov 28, 2022Zeotech Limited, Annual General Meeting, Nov 28, 2022.
Reported Earnings • Sep 21Full year 2022 earnings released: AU$0.003 loss per share (vs AU$0.002 loss in FY 2021)Full year 2022 results: AU$0.003 loss per share (further deteriorated from AU$0.002 loss in FY 2021). Net loss: AU$4.23m (loss widened 45% from FY 2021). Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has increased by 55% per year, which means it is well ahead of earnings.
공시 • Jul 28Zeotech Limited, Annual General Meeting, Aug 31, 2022Zeotech Limited, Annual General Meeting, Aug 31, 2022, at 14:00 E. Australia Standard Time. Location: Hyatt Hotel Canberra, 120 Commonwealth Ave, Yarralumla, ACT 2600 Yarrabah Australia Agenda: General Meeting of Shareholders.
공시 • May 31Zeotech Limited Achieves Successful Continuous Closed- Loop Circuit, Utilising Lithium Process By-Product Feedstock (Leached Spodumene) to Produce Pure Linde Type A Manufactured ZeoliteZeotech Limited advised that it has achieved a successful continuous closed- loop circuit, utilising lithium process by-product feedstock (leached spodumene) to produce pure Linde Type A manufactured zeolite. This demonstration of the Company's dual-feed pilot is a significant milestone in the program with both leached spodumene and kaolin feedstock options being processed through the circuit. The achievement of multiple closed-looped circuit runs utilising lithium process by-product provides important validation of the Company's proprietary flowsheet and will allow personnel from The University of Queensland ("UQ") and the Company to commence project planning for The Trailblazer University Program ("Trailblazer"), which includes industry partner, Covalent Lithium Pty Limited. Since receiving (new) leached spodumene samples in December 2021, UQ researchers have completed over 80 optimisation batch tests and 25 continuous tests completed on individual process steps, involving leaching, filtration/decanting, and precipitation. The pilot has produced over 3 kgs of pure Linde Type A manufactured zeolite product utilising lithium process by-product as feedstock. The pilot program's focus on lithium process by-product delivered an excellent outcome, highlighted by the Company being named as an industry partner in the successful Resources Technology and Critical Minerals Processing Trailblazer Program, led by Curtin University 2 in April 2022. The Trailblazer project will accelerate the commercialisation of Zeotech's proprietary cleantech innovation for lithium process by-product in collaboration with project partners, UQ and Covalent. The Trailblazer grant program provides Federal Government funding to select universities to boost prioritised research and development and drive commercialisation outcomes with industry partners. Next Steps: The completion of a successful continuous closed-loop circuit under the conditions of Zeotech's proprietary flowsheet represents a major step in accelerating Trailblazer planning, with the project's objective of constructing and commissioning a large-scale demonstration plant. Focus on the Company's dual-feed pilot program will remain on lithium process by-product until end of June 2022, in conjunction with commencement of Trailblazer project planning. Attention will then return to kaolin feedstock in early July 2022, following a successful continuous closed-loop circuit utilising Toondoon kaolin feedstock in November 2021.
Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Non-Executive Chairman Sylvia Tulloch was the last director to join the board, commencing their role in 2020. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
분석 기사 • Mar 22Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth PlansJust because a business does not make any money, does not mean that the stock will go down. For example, although...
Reported Earnings • Mar 08First half 2022 earnings: Revenues and EPS in line with analyst expectationsFirst half 2022 results: AU$0.001 loss per share (vs AU$0.001 loss in 1H 2021). Net loss: AU$2.22m (loss widened 32% from 1H 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has increased by 114% per year, which means it is well ahead of earnings.
공시 • Feb 24Zeotech Limited to Be Deleted from Other OTCZeotech Limited's ordinary shares (Australia) will be deleted from Other OTC effective February 23, 2022. The deletion is due to Inactive Security.
공시 • Nov 30Zeotech Limited Announces Pilot Program UpdateZeotech Limited announced that it has successfully completed its first continuous closed-loop circuit, utilising kaolin feedstock to produce pure Linde Type A synthetic zeolite product. This marks a significant step in progressing the Company's dual-feed pilot program. Successful bench-scale continuous closed-loop circuit achieved utilising kaolin feedstock to produce pure Linde Type A synthetic zeolite product. Over 110 optimisation batch tests undertaken using Toondoon kaolin and Li process by-product samples, undertaken since May 2021. Over 30 continuous tests completed on individual process steps, involving leaching, filtration/decanting, and precipitation. Plant and equipment procurement underway, with construction and commissioning of pilot plant on track to commence early First Quarter 2022. During the H2 2021, the team at UQ completed in excess of 155 batch and continuous test runs. This work, together with the earlier start date on kaolin test-work, has led to successful development of the first continuous closed-loop circuit utilising Toondoon kaolin as feedstock to produce pure Linde Type A synthetic zeolite product. Since June 2021, UQ researchers have completed over 70 optimisation batch tests across a range leaching and precipitation configurations from two separate samples of Li process by- product. Continuous tank reactor precipitation work has been successfully completed and the team is currently undertaking continuous leaching runs. The inclusion of two separate Li process by-product samples to the pilot program, has increased the variables in validating ZEO's proprietary flowsheet process steps. Despite this, Zeotech and UQ expect to achieve a continuous closed-loop circuit in the near term. The completion of a successful continuous closed-loop circuit under the conditions of Zeotech's proprietary flowsheet, represents a major step in developing the configuration and design data required for scale-up to pilot line construction and commissioning, which is scheduled to commence First Quarter 2022. The focus for the remainder of 2021 is aimed at further optimisation of process steps targeted at achieving a continuous closed-loop circuit utilising Li process by-product. In addition, procurement of plant and equipment for the pilot line set-up has accelerated with key items scheduled for delivery early 2022.
분석 기사 • Oct 27Zeotech (ASX:ZEO) Is In A Good Position To Deliver On Growth PlansEven when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Reported Earnings • Sep 28Full year 2021 earnings released: AU$0.002 loss per share (vs AU$0.003 loss in FY 2020)Full year 2021 results: Net loss: AU$2.92m (loss widened 5.9% from FY 2020). Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has increased by 103% per year, which means it is tracking significantly ahead of earnings growth.
공시 • May 24Zeotech Limited announced that it expects to receive AUD 3.7005 million in fundingZeotech Limited (ASX:ZEO) announced private placement of 52,864,286 shares at a price of AUD 0.07 per share for gross proceeds of AUD 3,700,500 on May 24, 2021. The transaction will include participation from sophisticated investors. The transaction has been approved by the board of directors of the company. The shares are expected to be issued on May 28, 2021.
분석 기사 • Apr 19We Think Zeotech (ASX:ZEO) Can Afford To Drive Business GrowthThere's no doubt that money can be made by owning shares of unprofitable businesses. Indeed, Zeotech ( ASX:ZEO ) stock...
Reported Earnings • Mar 18First half 2021 earnings released: AU$0.001 loss per share (vs AU$0.001 loss in 1H 2020)First half 2021 results: Net loss: AU$1.68m (loss widened 150% from 1H 2020). Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has increased by 87% per year, which means it is tracking significantly ahead of earnings growth.
분석 기사 • Feb 18Trade Alert: Anthony Sheridan At Zeotech Limited (ASX:ZEO), Has Just Spent AU$780k Buying 8.8% More SharesZeotech Limited ( ASX:ZEO ) shareholders (or potential shareholders) will be happy to see that insider Anthony Sheridan...
공시 • Feb 16Zeotech Limited Pilot Plant Program CommencesZeotech Limited announce that it has committed to the development and construction of a pilot plant and is undertaking an extensive test-work- program to further optimise the flowsheet of the Company's low-cost synthetic zeolite manufacturing technology to de-risk future commercial investment. Following the positive outcomes of extensive lab-scale work undertaken by researchers from UQ, since lodging a core provisional patent application in June 2019, for the manufacture (synthesis) of synthetic zeolites from kaolin or clay-based materials i.e., mine tailings or process residues, Zeotech has committed to undertake a comprehensive pilot plant program. The program will incorporate an artificial intelligence (machine learning) component to enhance understanding and application of piloting results, by building a comprehensive dataset and predictive capabilities. The pilot plant will provide Zeotech with increased confidence and certainty on the engineered flowsheet design and operational performance of the process circuit before committing to commercial zeolite production facilities. Zeotech's decision to proceed with the pilot plant is supported by continued positive lab-scale results delivered by research funded at UQ and based on the understanding that a well designed and constructed pilot plant is an integral component in the decision-making process required to determine critical economics and underpin future commercial plant strategy and financing. The pilot plant should also demonstrate the efficiency of Zeotech's novel and proprietary mineral processing technology and proficiency of the process design by producing very high-grade material on a continuous, customer sample scale, basis. The program's aim is to commission pilot plant in the December Quarter 2021. The University of Queensland's Associate Professor James Vaughan and Dr. Hong (Marco) Peng from the School of Chemical Engineering will provide technical support for the pilot plant program's studies. Pilot Plant Funding: As announced on 5 January 2021, the Company raised $1.7 million to support funding of the pilot plant program. It is important to note that as the pilot plant research program revolves around validating Zeotech's patent-pending technology, it is classified as Research and Development and accordingly it will be eligible for the Australian Government's R&D tax incentive scheme. Zeotech targeting Type A zeolites: The Company's novel and proprietary mineral processing technology provides potential access to the AUD 2.6 billion global Type A zeolite market, with a focus on high value molecular sieve zeolites, which achieve prices in excess of AUD 2,850 per tonne.
공시 • Feb 08Zeotech Limited Executes Research Agreement with UQ to Evaluate Carbon Capture Using Synthetic ZeolitesZeotech Limited announced it has executed a dedicated research agreement with The University of Queensland ("UQ") to evaluate the performance of synthetic zeolites in the field of carbon capture, a market that is projected to reach USD 6.15 billion by 2027. Zeotech is assessing how to leverage its novel and proprietary mineral processing technology for the low-cost synthesis of synthetic zeolites to deliver economically feasible environmental management solutions for carbon capture. The carbon capture research program will commence 1 March 2021 and will be carried out over a nine-month period. The program will consist of the following stages: Characterisation of synthetic zeolites and commercial adsorbents - this will involve building a database of different types of the synthetic zeolites and commercial adsorbents, following their characterisation, and comparing properties; Carbon dioxide adsorption capacity and selectivity measurement - this will involve measuring and comparing the carbon dioxide (CO2) adsorption capacity of the synthetic zeolites and commercial adsorbents. The synthetic zeolites selectivity of CO2 over other gases such as N2 will also be investigated; and Granulation study of synthetic zeolite products - this will involve an agglomeration study of synthetic zeolites will be carried out in this stage. The preparation process of the synthetic zeolite agglomerate will be explored, and the carbon capture performance of these bulk adsorbents will be evaluated. Zeotech's carbon capture research program will also incorporate detailed economic analysis of: The use of different synthetic zeolites produced by Zeotech and the commercial adsorbents for carbon capture and selectivity; and Granulation of synthetic zeolite products and the commercial adsorbents for carbon capture and selectivity. Growing environmental concerns regarding global warming and climate change have motivated researchers to develop more efficient and improved processes for CO2 capture from large point sources of CO2. Adsorption processes using solid sorbents capable of capturing CO2 from flue gas streams have shown many potential advantages, compared to other conventional CO2 capture processes using aqueous amine solvents. Microporous crystalline framework materials such as synthetic zeolites are widely used in the field of gas separation and purification, commercially. Synthetic zeolites have shown promising results for separation of CO2 from gas streams and there is much published literature concerning CO2 adsorption over different types of zeolites. Zeotech's aim is to leverage the economic benefits of its synthetic zeolite mineral processing technology. For example, UQ's Chemical Engineering team has demonstrated up to 70% reduction in energy consumption in the thermal activation stage and up to 80% reduction in production time in the subsequent zeolite precipitation steps, in the synthesis of synthetic zeolites, coupled with the excellent structural properties of the synthetic zeolite to produce low-cost solid adsorbent for commercial CO2 capture to reduce greenhouse gases. Zeotech is also pleased to advise it continues to grow its in-house technical team, with the employment of Mr. John Vogrin on a full-time basis. Mr. Vogrin is a PhD candidate (awaiting examination) and Alumina Quality Workshop scholar in the School of Chemical Engineering at The University of Queensland. He has recently submitted his thesis on the hydrothermal synthesis of zeolites in industrial processes such as the Bayer process and anion incorporation into their structure. John's expertise includes XRD (quantitative/qualitative), ICP, XRF, FE-SEM, TGA, PSD and UV-Raman spectroscopy for materials characterisation. His latest publication is 'Influence of Chloride on Sodium Aluminosilicate Solubility in Bayer Liquor'. He holds a Bachelor of Engineering (B.E.) in Chemical and Metallurgical Engineering (Honours).
분석 기사 • Jan 25Here's What Zeotech Limited's (ASX:ZEO) Shareholder Ownership Structure Looks LikeIf you want to know who really controls Zeotech Limited ( ASX:ZEO ), then you'll have to look at the makeup of its...
공시 • Jan 12Zeotech Limited Announces resignation of John Goody as Non-Executive DirectorZeotech Limited announced that Mr. John Goody has resigned as a non-executive director of the Company.
공시 • Oct 05Metalsearch Limited Announces Participating in Agronomic Trials to Evaluate the Performance of Synthetic Zeolites Across A Range of Agricultural ApplicationsMetalsearch Limited announced it is participating in agronomic trials to evaluate the performance of synthetic zeolites across a range of agricultural applications. The trials will be undertaken in collaboration with Griffith University and the University of Queensland. MSE is exploring the application of synthetic zeolites in the agricultural industry after being introduced to Griffith University by the University of Queensland, in order to link into an agronomic zeolite trial program to be conducted over the next 6-9 months. The program will consist of: Zeolite sorption and desorption experimentation; Agronomic performance testing via glasshouse pot trials, benchmarking against conventional soil amendment; Assessing plant growth performance under optimal water-availability and drought conditions; and Pesticide-destruction experiments - testing the photocatalytic oxidation potential of zeolites amended with commonly-encountered pesticides in Australian agriculture. MSE considers one of the inhibitors to the wider commercial adoption of synthetic zeolites in the agricultural sector has been the cost of production. The ability to produce low-cost synthetic zeolites from kaolin or suitable zero-cost mine waste streams using the University of Queensland's developed mineral processing technology enables MSE to tangibly investigate end-product strategies to exploit its patent-pending zeolite mineral processing technologies. Zeolites have a range of agricultural applications, such as; soil amendment i.e. improve water-holding capacity and aid fertilizer uptake; fertilizer additives i.e. aid slow-release; animal feed additives i.e. dietary supplement and mycotoxin adsorption; animal waste treatment i.e. increasing nitrogen retentivity and controlling moisture; and aquaculture i.e. remove ammonium, oxygen generation and as a feed supplement. Griffith University's agronomic zeolite trials will incorporate detailed economic analysis, which may potentially translate into a more intensive collaboration between Griffith University, the University of Queensland and MSE - the objective being to set the foundation for specialised synthetic zeolite Agri-product development studies.
공시 • Jul 31Metalsearch Limited announced that it has received AUD 1.6575 million in fundingLaconia Resources Limited (ASX:LCR) a private placement of 127,500,000 common shares for AUD 0.013 per share for gross proceeds of AUD 1,657,500 on July 28, 2020. The transaction included participation from sophisticated investors.